Activated RET and ROS: two new driver mutations in lung adenocarcinoma

Autor Bos, Marc, Gardizi, Masyar, Schildhaus, Hans-Ulrich, Buettner, Reinhard, Wolf, Juergen
Vydáno v Transl Lung Cancer Res (2013)

Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology

Autor Alidousty, Christina, Baar, Till, Heydt, Carina, Wagener-Ryczek, Svenja, Kron, Anna, Wolf, Juergen, Buettner, Reinhard, Schultheis, Anne Maria
Vydáno v J Thorac Dis (2019)

Foetal age determination and development in elephants

Autor Hildebrandt, Thomas, Drews, Barbara, Gaeth, Ann P, Goeritz, Frank, Hermes, Robert, Schmitt, Dennis, Gray, Charlie, Rich, Peter, Streich, Wolf Juergen, Short, Roger V, Renfree, Marilyn B
Vydáno 2006

OTHR-14. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING FET PET IN PATIENTS WITH MELANOMA AND LUNG CANCER BRAIN METASTASES: INITIAL EXPERIENCES

Autor Galldiks, Norbert, Abdulla, Diana, Scheffler, Matthias, Schweinsberg, Viola, Schlaak, Max, Kreuzberg, Nicole, Landsberg, Jenny, Lohmann, Philipp, Ceccon, Garry, Werner, Jan-Michael, Celik, Eren, Ruge, Maximilian, Kocher, Martin, Marnitz, Simone, Fink, Gereon, Langen, Karl-Josef, Wolf, Juergen, Mauch, Cornelia
Vydáno v Neurooncol Adv (2019)

PAN-CANCER EFFICACY OF VEMURAFENIB IN BRAF(V600)-MUTANT NON-MELANOMA CANCERS

Autor Subbiah, Vivek, Puzanov, Igor, Blay, Jean-Yves, Chau, Ian, Lockhart, A. Craig, Raje, Noopur S., Wolf, Juergen, Baselga, Jose, Meric-Bernstam, Funda, Roszik, Jason, Diamond, Eli L., Riely, Gregory J., Sherman, Eric J., Riehl, Todd, Pitcher, Bethany, Hyman, David M.
Vydáno v Cancer Discov (2020)

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer: The SELECT-1 Randomized Cli...

Autor Jänne, Pasi A., van den Heuvel, Michel M., Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crinò, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Juergen, Garrido, Pilar, Poltoratskiy, Artem, Mariani, Gabriella, Ghiorghiu, Dana, Kilgour, Elaine, Smith, Paul, Kohlmann, Alexander, Carlile, David J., Lawrence, David, Bowen, Karin, Vansteenkiste, Johan
Vydáno v JAMA (2017)

CMET-22. CAPMATINIB (INC280) IN METΔEX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY

Autor Heist, Rebecca S, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B, Groen, Harry J M, Tan, Daniel S W, Hida, Toyoaki, de Jonge, Maja, V Orlov, Sergey, Smit, Egbert F, Souquet, Pierre-Jean, Vansteenkiste, Johan, Le Mouhaer, Sylvie, Robeva, Anna, Waldron-Lynch, Maeve, Giovannini, Monica, Wolf, Juergen
Vydáno v Neuro Oncol (2019)

BM-32 CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL

Autor Shaw, Alice, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Ross Camidge, D., Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Geraldes, Margarida, Sen, Paramita, Boral, Anthony J., Yovine, Alejandro, Kim, Dong-Wan
Vydáno 2014

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

Autor Shaw, Alice T., Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Camidge, D. Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Lau, Yvonne Y., Goldwasser, Meredith, Boral, Anthony L., Engelman, Jeffrey A.
Vydáno 2014

Efficacy of BGJ398, a fibroblast growth factor receptor 1–3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations

Autor Pal, Sumanta K., Rosenberg, Jonathan E., Hoffman-Censits, Jean H., Berger, Raanan, Quinn, David I., Galsky, Matthew D., Wolf, Juergen, Dittrich, Christian, Keam, Bhumsuk, Delord, Jean-Pierre, Schellens, Jan H. M., Gravis, Gwenaelle, Medioni, Jacques, Maroto, Pablo, Sriuranpong, Virote, Charoentum, Chaiyut, Burris, Howard A., Grünwald, Viktor, Petrylak, Daniel, Vaishampayan, Ulka, Gez, Eliahu, De Giorgi, Ugo, Lee, Jae-Lyun, Voortman, Jens, Gupta, Sumati, Sharma, Sunil, Mortazavi, Amir, Vaughn, David J., Isaacs, Randi, Parker, Katie, Chen, Xueying, Yu, Kun, Porter, Dale, Porta, Diana Graus, Bajorin, Dean F.
Vydáno v Cancer Discov (2018)

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

Autor Gautschi, Oliver, Milia, Julie, Filleron, Thomas, Wolf, Juergen, Carbone, David P., Owen, Dwight, Camidge, Ross, Narayanan, Vignhesh, Doebele, Robert C., Besse, Benjamin, Remon-Masip, Jordi, Janne, Pasi A., Awad, Mark M., Peled, Nir, Byoung, Chul-Cho, Karp, Daniel D., Van Den Heuvel, Michael, Wakelee, Heather A., Neal, Joel W., Mok, Tony S.K., Yang, James C.H., Ou, Sai-Hong Ignatius, Pall, Georg, Froesch, Patrizia, Zalcman, Gérard, Gandara, David R., Riess, Jonathan W., Velcheti, Vamsidhar, Zeidler, Kristin, Diebold, Joachim, Früh, Martin, Michels, Sebastian, Monnet, Isabelle, Popat, Sanjay, Rosell, Rafael, Karachaliou, Niki, Rothschild, Sacha I., Shih, Jin-Yuan, Warth, Arne, Muley, Thomas, Cabillic, Florian, Mazières, Julien, Drilon, Alexander
Vydáno v J Clin Oncol (2017)